Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020


Investor Portal

Investor Portal

Phacilitate Leaders Europe - opportunity           LSX - life science executive leaders

Education & Investment for Advanced Therapies

Advanced therapies are such a young and dynamic field, and for over 16 years we’ve been dedicated to learning the commercial and clinical challenges that are key to finding the next unicorn.

Phacilitate Leaders Europe 2019 is the first event of its kind that will provide the opportunity for you to meet potential clients, whilst also engaging in educational sessions that will enhance your understanding of the advanced therapies landscape in Europe. 


  • First-hand experience from academic leaders 
  • Understand the next generation of exciting clinical and technology businesses 
  • Updates on the latest trends and insights from Europe


  • Access our 1-2-1 partnering system
  • Meet European tech transfer offices at our pre-event networking drinks in the Serpentine gallery
  • Join a dedicated investor and biotech
    networking and partnering lunch

Take a glance at just some of the investment companies who have already registered for the event this year

phacilitate leaders europe investment companies event conference investors

Due to the increased volume of M&A and investment activity in cell and gene therapy, we've incorporated an investment and innovation track into the agenda. This has been developed to help you solve the most pressing challenges you’ll face when investing in an advanced therapy company.

Take a glance at our featured investment content...


Funding, Commercialisation and Market Access for Advanced Therapies


Investment for Advanced Therapies 


Quantitative Understandings of Risk in Cell and Gene Therapies

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd